Hologic Inc. HOLX, +1.95% shares rose in the extended session Wednesday as the medical technology company’s earnings fell short of Wall Street estimates but revenue topped them. Hologic shares rose 4.6% after hours, following a 2% gain to close the regular session at $41.26. The company reported fiscal fourth-quarter net income of $50.5 million, or 18 cents a share, compared with $82.7 million, or 29 cents a share, in the year-ago period. Adjusted earnings were 58 cents a share. Revenue rose to $813.5 million from $802.9 million in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of 59 cents a share on revenue of $806.3 million. For the year, Hologic expects earnings of $2.38 to $2.42 a share on revenue of $3.29 billion to $3.34 billion, while analysts had forecast $2.42 a share on revenue of $3.31 billion.
Have breaking news sent to your inbox. Subscribe to MarketWatch’s free Bulletin emails. Sign up here.